Search research articles
Contact Us
Filters
Showing results (161-170 of 229) with videos related to
Page
of 23
Sort By:
Nature Communications
|
September 1, 2018
Identification of a novel anoikis signalling pathway using the fungal virulence factor gliotoxin
Florian Haun, Simon Neumann, Lukas Peintner, et al.
Blood Advances
|
May 22, 2025
Molecular profiling of primary renal diffuse large B-cell lymphoma unravels a proclivity for immune-privileged tropism
Axel Künstner, Vera von Kopylow, Philipp Lohneis, et al.
Frontiers in Immunology
|
October 10, 2022
Genetic analysis of CFH and MCP in Egyptian patients with immune-complex proliferative glomerulonephritis
Heba R Gouda, Iman M Talaat, Amal Bouzid, et al.
Frontiers in Oncology
|
September 18, 2023
Molecular profiling and specific targeting of gemcitabine-resistant subclones in heterogeneous pancreatic cancer cell populations
Benedikt Färber, Olga Lapshyna, Axel Künstner, et al.
Nature Cell Biology
|
April 18, 2017
The EMT-activator Zeb1 is a key factor for cell plasticity and promotes metastasis in pancreatic cancer
Angela M Krebs, Julia Mitschke, María Lasierra Losada, et al.
Frontiers in Immunology
|
December 12, 2019
Complement Receptor 1 (CR1, CD35) Polymorphisms and Soluble CR1: A Proposed Anti-inflammatory Role to Quench the Fire of "Fogo Selvagem" Pemphigus Foliaceus
Luana Caroline Oliveira, Gabriela Canalli Kretzschmar, Andressa Cristina Moraes Dos Santos, et al.
JMIR Research Protocols
|
September 4, 2024
Identifications of Similarity Metrics for Patients With Cancer: Protocol for a Scoping Review
Iryna Manuilova, Jan Bossenz, Annemarie Bianka Weise, et al.
Annals of Hematology
|
February 24, 2025
The mutational landscape and its longitudinal dynamics in relapsed and refractory classic Hodgkin lymphoma
Hanno Witte, Axel Künstner, Thomas Hahn, et al.
Leukemia
|
April 24, 2025
Ruxolitinib mediated paradoxical JAK2 hyperphosphorylation is due to the protection of activation loop tyrosines from phosphatases
Sivahari P Gorantla, Lorenz Oelschläger, Gerin Prince, et al.
Oncotarget
|
November 10, 2016
ERN1 and ALPK1 inhibit differentiation of bi-potential tumor-initiating cells in human breast cancer
Juliane Strietz, Stella S Stepputtis, Bogdan-Tiberius Preca, et al.
Page
of 23
Search research articles
Search
Showing results (161-170 of 229) with videos related to
Sort By:
Page
of 23
Nature Communications
|
September 1, 2018
Identification of a novel anoikis signalling pathway using the fungal virulence factor gliotoxin
Florian Haun, Simon Neumann, Lukas Peintner, et al.
Blood Advances
|
May 22, 2025
Molecular profiling of primary renal diffuse large B-cell lymphoma unravels a proclivity for immune-privileged tropism
Axel Künstner, Vera von Kopylow, Philipp Lohneis, et al.
Frontiers in Immunology
|
October 10, 2022
Genetic analysis of CFH and MCP in Egyptian patients with immune-complex proliferative glomerulonephritis
Heba R Gouda, Iman M Talaat, Amal Bouzid, et al.
Frontiers in Oncology
|
September 18, 2023
Molecular profiling and specific targeting of gemcitabine-resistant subclones in heterogeneous pancreatic cancer cell populations
Benedikt Färber, Olga Lapshyna, Axel Künstner, et al.
Nature Cell Biology
|
April 18, 2017
The EMT-activator Zeb1 is a key factor for cell plasticity and promotes metastasis in pancreatic cancer
Angela M Krebs, Julia Mitschke, María Lasierra Losada, et al.
Frontiers in Immunology
|
December 12, 2019
Complement Receptor 1 (CR1, CD35) Polymorphisms and Soluble CR1: A Proposed Anti-inflammatory Role to Quench the Fire of "Fogo Selvagem" Pemphigus Foliaceus
Luana Caroline Oliveira, Gabriela Canalli Kretzschmar, Andressa Cristina Moraes Dos Santos, et al.
JMIR Research Protocols
|
September 4, 2024
Identifications of Similarity Metrics for Patients With Cancer: Protocol for a Scoping Review
Iryna Manuilova, Jan Bossenz, Annemarie Bianka Weise, et al.
Annals of Hematology
|
February 24, 2025
The mutational landscape and its longitudinal dynamics in relapsed and refractory classic Hodgkin lymphoma
Hanno Witte, Axel Künstner, Thomas Hahn, et al.
Leukemia
|
April 24, 2025
Ruxolitinib mediated paradoxical JAK2 hyperphosphorylation is due to the protection of activation loop tyrosines from phosphatases
Sivahari P Gorantla, Lorenz Oelschläger, Gerin Prince, et al.
Oncotarget
|
November 10, 2016
ERN1 and ALPK1 inhibit differentiation of bi-potential tumor-initiating cells in human breast cancer
Juliane Strietz, Stella S Stepputtis, Bogdan-Tiberius Preca, et al.
Page
of 23